Dosage forms of risedronate

Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Particulate form

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

424489, 424463, 424486, 424482, A61K 916, A61K 950

Patent

active

056227213

ABSTRACT:
The present invention is directed to a novel enteric-coated oral dosage form of a risedronate active ingredient comprised of a safe and effective amount of a pharmaceutical composition which is comprised of a risedronate active ingredient and pharmaceutically-acceptable excipients. Said dosage forms prohibit the exposure of the risedronate active ingredient to the epithelial and mucosal tissues of the buccal cavity, pharynx, esophagus, and stomach and thereby protects said tissues from erosion, ulceration or other like irritation. Accordingly, the said dosage forms effect the delivery to the lower gastrointestinal tract of said human or other mammal of a safe and effective amount of the risedronate active ingredient, and substantially alleviate the esophagitis or esophageal irritation which occasionally accompanies the oral administration of risedronate active ingredients.

REFERENCES:
patent: 4716041 (1987-12-01), Kjornaes
patent: 4786505 (1988-11-01), Lovgren
patent: 5096717 (1992-03-01), Wirth et al.
patent: 5431920 (1995-07-01), Bechard et al.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Dosage forms of risedronate does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Dosage forms of risedronate, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dosage forms of risedronate will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-339963

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.